(Q35201000)

7 August 2017

1 reference

title

Ertapenem: a review of its use in the management of bacterial infections (English)

1 reference

7 August 2017

1

Monique Curran

1 reference

7 August 2017

Dene Simpson

2

1 reference

7 August 2017

Caroline Perry

series ordinal

3

1 reference

7 August 2017

language of work or name

1 reference

1 January 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

63

1 reference

7 August 2017

issue

17

1 reference

7 August 2017

page(s)

1855-1878

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363170-00006

7 August 2017

exact match

0 references

cites work

Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections

1 reference

12 December 2020

Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections. European and North American experience.

1 reference

12 December 2020

In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics

1 reference

12 December 2020

Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection

1 reference

12 December 2020

BTS Guidelines for the Management of Community Acquired Pneumonia in Adults

1 reference

12 December 2020

Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis

1 reference

12 December 2020

Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents

1 reference

12 December 2020

Pharmacokinetics of intramuscularly administered ertapenem

1 reference

12 December 2020

Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model

1 reference

12 December 2020

Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections

1 reference

12 December 2020

A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults

1 reference

12 December 2020

Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study

1 reference

12 December 2020

In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates

1 reference

12 December 2020

Ertapenem. A review of its microbiologic, pharmacokinetic and clinical aspects.

1 reference

12 December 2020

Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study

1 reference

12 December 2020

In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains

1 reference

12 December 2020

General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam

1 reference

12 December 2020

Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study

1 reference

12 December 2020

In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers

1 reference

12 December 2020

Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.

1 reference

12 December 2020

In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds

1 reference

12 December 2020

Recent developments in carbapenems

1 reference

12 December 2020

The postantibiotic effect of meropenem and imipenem on selected bacteria

1 reference

12 December 2020

A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia

1 reference

12 December 2020

Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain

1 reference

12 December 2020

Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases

1 reference

12 December 2020

Meropenem: a review of its use in patients in intensive care

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

A comparative study on the convulsant activity of carbapenems and beta-lactams

1 reference

12 December 2020

Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections

1 reference

12 December 2020

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria

1 reference

12 December 2020

Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents

1 reference

12 December 2020

The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC.

1 reference

12 December 2020

Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections

1 reference

12 December 2020

In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains

1 reference

12 December 2020

Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use.

1 reference

12 December 2020

Emerging carbapenemases in Gram-negative aerobes

1 reference

12 December 2020

Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents

1 reference

12 December 2020

Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections

1 reference

12 December 2020

Antimicrobial treatment of intra-abdominal infections

1 reference

12 December 2020

In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteria

1 reference

12 December 2020

Monobactams and carbapenems for treatment of intraabdominal infections

1 reference

12 December 2020

Meropenem: an updated review of its use in the management of intra-abdominal infections

1 reference

12 December 2020

Comparative pharmacokinetics of the carbapenems: clinical implications

1 reference

12 December 2020

Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults

1 reference

12 December 2020

Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers

1 reference

12 December 2020

Ertapenem versus Piperacillin-Tazobactam for Treatment of Mixed Anaerobic Complicated Intra-Abdominal, Complicated Skin and Skin Structure, and Acute Pelvic Infections

1 reference

12 December 2020

1 reference

12 December 2020

Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement

1 reference

12 December 2020

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia

1 reference

12 December 2020

The epidemiology of missed medication doses in hospitalized patients.

1 reference

12 December 2020

Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data

1 reference

12 December 2020

A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults

1 reference

12 December 2020

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections

1 reference

12 December 2020

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

12 December 2020

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

1 reference

12 December 2020

In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials

1 reference

12 December 2020

Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes

1 reference

12 December 2020

General guidelines for the clinical evaluation of anti-infective drug products. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria

1 reference

12 December 2020

10.2165/00003495-200363170-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

7 August 2017

1046019615

0 references

1 reference